Literature DB >> 11845032

[Hormonal perturbations in fibromyalgia].

J L Schlienger1, A E Perrin, F Grunenberger, B Goichot.   

Abstract

Fibromyalgia is a syndrome characterized by chronic musculoskeletal pain and fatigue without biological detectable disturbances. The mechanisms of this disease are unknown. It has been postulated that it can be the consequence of a chronic stress mediated mainly through the hypothalamo-pituitary-adrenal axis and the sympathetic nervous system. These fields have been extensively studied. Results were scattered and non convincing. A reduction of growth hormone and IGF-1 levels described in a third of patients has led to a double blind random clinical trial with biogenetic growth hormone. Results were equivocal . Other hormonal systems are grossly normals and circadian rhythms are unaltered. Despite some arguments in favour of a CRH neurons hyperactivity, these results are not able to consolide a particular physiopathological mechanism and to argument for a new therapeutic approach. Many of the abnormalities may be the consequence of psychological disturbances.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11845032

Source DB:  PubMed          Journal:  Ann Endocrinol (Paris)        ISSN: 0003-4266            Impact factor:   2.478


  2 in total

1.  [Altered function of the hypothalamic-pituitary-adrenal axis in patients with acute, chronic and episodic pain].

Authors:  M Strittmatter; O Bianchi; D Ostertag; M Grauer; C Paulus; C Fischer; S Meyer
Journal:  Schmerz       Date:  2005-04       Impact factor: 1.107

2.  Ghrelin plasmatic levels in patients with fibromyalgia.

Authors:  Miguel Otero; Ruben Nogueiras; Francisca Lago; Juan Meijide; Juan Amarelo; Antonio Mera; Juan Gomez-Reino; Oreste Gualillo
Journal:  Rheumatol Int       Date:  2003-09-05       Impact factor: 2.631

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.